Imaradenant
| Drug Information | |||
|---|---|---|---|
| Image | |||
| Identifiers
CAS Number ATC Code PubChem DrugBank ChemSpider ID UNII KEGG ChEBI ChEMBL IUPAC Name |
Chemical Data
C H N O Molecular Weight | ||
Imaradenant is an investigational drug that is being studied for its potential use in the treatment of various types of cancer. It is classified as an adenosine A2A receptor antagonist, which means it works by blocking the action of adenosine at the A2A receptor. This mechanism is thought to enhance the immune system's ability to fight cancer by preventing adenosine from suppressing immune cell activity in the tumor microenvironment.
Mechanism of Action[edit | edit source]
Adenosine is a purine nucleoside that plays a crucial role in biochemical processes, such as energy transfer and signal transduction. In the context of cancer, adenosine is often found in high concentrations within the tumor microenvironment, where it can inhibit the activity of immune cells such as T cells and natural killer (NK) cells. By blocking the A2A receptor, imaradenant aims to counteract this immunosuppressive effect, thereby promoting an anti-tumor immune response.
Clinical Development[edit | edit source]
Imaradenant is currently undergoing clinical trials to evaluate its safety and efficacy in patients with various types of cancer, including non-small cell lung cancer, melanoma, and renal cell carcinoma. These trials are designed to assess the drug's ability to improve outcomes when used alone or in combination with other therapies, such as immune checkpoint inhibitors like pembrolizumab or nivolumab.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of imaradenant includes its absorption, distribution, metabolism, and excretion. Studies have shown that the drug is orally bioavailable, with a half-life that supports once-daily dosing. The metabolism of imaradenant is primarily hepatic, and it is excreted through both renal and fecal pathways.
Side Effects[edit | edit source]
As with many investigational drugs, the side effects of imaradenant are still being characterized. Commonly reported adverse effects in clinical trials include fatigue, nausea, and headache. More serious side effects are being closely monitored as the drug progresses through clinical development.
Future Directions[edit | edit source]
Research is ongoing to better understand the full potential of imaradenant in cancer therapy. This includes exploring its use in combination with other immunotherapies and targeted therapies, as well as identifying biomarkers that may predict response to treatment.
Also see[edit | edit source]
| Receptor Antagonists | |
|---|---|
| Receptor Type | Example Antagonists |
| Adrenergic receptor | Propranolol, Prazosin |
| Cholinergic receptor | Atropine, Scopolamine |
| Dopamine receptor | Haloperidol, Clozapine |
| Histamine receptor | Ranitidine, Diphenhydramine |
| Serotonin receptor | Ondansetron, Risperidone |
| Glutamate receptor | Memantine, Ketamine |
| GABA receptor | Flumazenil, Bicuculline |
| Opioid receptor | Naloxone, Naltrexone |
| Angiotensin receptor | Losartan, Valsartan |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
